WebMD Health Corp. Upgraded to “Outperform” by Zacks (WBMD)
WebMD Health Corp. (NASDAQ:WBMD) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a note issued to investors on Wednesday, Analyst Ratings Network reports. The firm currently has a $36.40 target price on the stock. Zacks‘ price objective suggests a potential upside of 8.79% from the stock’s previous close.
Shares of WebMD Health Corp. (NASDAQ:WBMD) traded down 5.02% during mid-day trading on Wednesday, hitting $31.78. The stock had a trading volume of 954,522 shares. WebMD Health Corp. has a 1-year low of $13.13 and a 1-year high of $35.28. The stock’s 50-day moving average is $32.33 and its 200-day moving average is $27.92. The company’s market cap is $1.576 billion. WebMD Health Corp. also was the target of some unusual options trading activity on Monday. Stock traders bought 10,807 put options on the stock. This is an increase of approximately 625% compared to the average daily volume of 1,490 put options.
WebMD Health Corp. (NASDAQ:WBMD) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.05 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.06 by $0.01. The company had revenue of $125.30 million for the quarter, compared to the consensus estimate of $124.43 million. The company’s quarterly revenue was up 11.2% on a year-over-year basis. Analysts expect that WebMD Health Corp. will post $0.25 EPS for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Raymond James raised their price target on shares of WebMD Health Corp. (NASDAQ:WBMD) from $36.00 to $39.00 in a research note to investors on Tuesday, August 6th. They now have a “strong-buy” rating on the stock. Separately, analysts at Stifel Nicolaus reiterated a “buy” rating on shares of WebMD Health Corp. (NASDAQ:WBMD) in a research note to investors on Thursday, August 1st. They now have a $40.00 price target on the stock, up previously from $35.00. Finally, analysts at Stifel Nicolaus reiterated a “buy” rating on shares of WebMD Health Corp. (NASDAQ:WBMD) in a research note to investors on Monday, July 15th. They now have a $35.00 price target on the stock.
One investment analyst has rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $32.08.
In other WebMD Health Corp. news, Chairman Martin J. Wygod sold 15,500 shares of the stock on the open market in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $32.96, for a total transaction of $510,880.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
WebMD Health Corp. is a provider of health information services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals, mobile platforms and health-focused publications.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.